Realizing individualized cancer treatment through patient genome sequencing

Recent Publications

Otsuka, M., Okamoto, Y., Hasebe, A., Shirahama, H. and Tomida, A.
HER3 enhances ATF4 induction and survival in breast cancer cells during endoplasmic reticulum stress.
Biochem. Biophys. Res. Commun., 797, 153215 (2026)
Yokomura, M., Nagano, S., Kawamoto, H., Hirohashi, Y., Torigoe, T., Asakage, T. and Katayama, R.
Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity.
Cancer Immunol. Immunother., 75, 33 (2026)
Wang, H., Yang, J., Katayama, R., Matusaki, M., Miyao, T., Li, Y. and Zhou, J.
NuclSeg-v2.0: Nuclei segmentation using semi-supervised stain deconvolution with real-time user feedback.
Pattern Recognit, in press (2025)
Wang, X., Shinjo, K., Kumegawa, K., Maruyama, R., Mii, S., Shiraki, Y., Nishimura, T., Murofushi, Y., Suzuki, M., Kabasawa, T., Futakuchi, M., Kanai, A., Suzuki, Y., Enomoto, A. and Kondo, Y.
Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.
Br. J. Cancer, in press (2025)
Toyohara, Y., Sone, K., Kumegawa, K., Yamamoto, Y., Hachijo, R., Kukita, A., Taguchi, A., Ikemura, M., Miyamoto, Y., Tanikawa, M., Iriyama, T., Mori, M., Hamamoto, R., Ushiku, T., Oda, K., Hirota, Y., Maruyama, R. and Osuga, Y.
Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma.
BMC Cancer, 25, 1873 (2025)

more